Sibilla Salvadeo

2.0k citations

51 papers · 1.6k indexed · h-index 24

Endocrinology, Diabetes and Metabolism top 1%
Molecular Biology
Cardiology and Cardiovascular Medicine top 10%
Epidemiology top 10%
Surgery top 10%

Co-authors: Giuseppe Derosa Arrigo F.G. Cicero Angela D’Angelo Ilaria Ferrari Alessia Gravina Leonardina Ciccarelli Mario N. Piccinni Pamela Maffioli
Topics: Diabetes Treatment and Management (22 papers)Metabolism, Diabetes, and Cancer (21 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cardiology and Cardiovascular Medicine Pharmacology
Journals: SHILAP Revista de lepidopterologíaMetabolism Biomedicine & Pharmacotherapy
Partner nations: Italy Russia

In The Last Decade

Sibilla Salvadeo

50 papers receiving 1.5k citations

Peers

Countries citing papers authored by Sibilla Salvadeo

Since Specialization

Citations

This map shows the geographic impact of Sibilla Salvadeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibilla Salvadeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibilla Salvadeo more than expected).

Fields of papers citing papers by Sibilla Salvadeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibilla Salvadeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibilla Salvadeo. The network helps show where Sibilla Salvadeo may publish in the future.

Co-authorship network of co-authors of Sibilla Salvadeo

This figure shows the co-authorship network connecting the top 25 collaborators of Sibilla Salvadeo. A scholar is included among the top collaborators of Sibilla Salvadeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibilla Salvadeo. Sibilla Salvadeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination 2010 ·SHILAP Revista de lepidopterología ·Giuseppe Derosa,Sibilla Salvadeo	1
2	Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects 2010 ·Microvascular Research ·Giuseppe Derosa,Angela D’Angelo,Sibilla Salvadeo,Ilaria Ferrari,Elena Fogari,Alessia Gravina,Roberto Mereu,Ilaria Palumbo,Pamela Maffioli,Sabrina Randazzo,Arrigo F.G. Cicero	20
3	Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension 2010 ·Hypertension Research ·Roberto Fogari,Annalisa Zoppi,Sibilla Salvadeo,Amedeo Mugellini,Pierangelo Lazzari,(unknown),Giuseppe Derosa	12
4	Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients 2010 ·Hormone and Metabolic Research ·Giuseppe Derosa,Pamela Maffioli,Ilaria Ferrari,Roberto Mereu,P. D. Ragonesi,Fabrizio Querci,(unknown),(unknown),Leonardina Ciccarelli,Mario N. Piccinni,Angela D’Angelo,Sibilla Salvadeo	44
5	Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects 2010 ·Microvascular Research ·Giuseppe Derosa,Ilaria Ferrari,Angela D’Angelo,Sibilla Salvadeo,Elena Fogari,Alessia Gravina,Roberto Mereu,Ilaria Palumbo,Pamela Maffioli,Sabrina Randazzo,Arrigo F.G. Cicero	21
6	Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatment 2009 ·Biomedicine & Pharmacotherapy ·Giuseppe Derosa,Angela D’Angelo,Sibilla Salvadeo,Ilaria Ferrari,Elena Fogari,Alessia Gravina,Roberto Mereu,Ilaria Palumbo,Pamela Maffioli,Sabrina Randazzo,Arrigo F.G. Cicero	20
7	Oral fat load effects on inflammation and endothelial stress markers in healthy subjects 2009 ·Heart and Vessels ·Giuseppe Derosa,Ilaria Ferrari,Angela D’Angelo,Sibilla Salvadeo,Elena Fogari,Alessia Gravina,Roberto Mereu,Ilaria Palumbo,Pamela Maffioli,Sabrina Randazzo,Arrigo F.G. Cicero	35
8	Oral Glucose Tolerance Test Effects on Endothelial Inflammation Markers in Healthy Subjects and Diabetic Patients 2009 ·Hormone and Metabolic Research ·Giuseppe Derosa,Angela D’Angelo,Sibilla Salvadeo,Ilaria Ferrari,Elena Fogari,Alessia Gravina,Roberto Mereu,Ilaria Palumbo,Pamela Maffioli,Sabrina Randazzo,Arrigo F.G. Cicero	33
9	Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 2009 ·Metabolism ·Giuseppe Derosa,Pamela Maffioli,Sibilla Salvadeo,Ilaria Ferrari,Alessia Gravina,Roberto Mereu,Ilaria Palumbo,Angela D’Angelo,Arrigo F.G. Cicero	21
10	Matrix Metalloproteinase-2 and -9 Levels in Obese Patients 2008 ·Endothelium ·Giuseppe Derosa,(unknown),Angela D’Angelo,Carmine Tinelli,Sibilla Salvadeo,Leonardina Ciccarelli,Mario N. Piccinni,Alessia Gravina,(unknown),Pamela Maffioli,Arrigo F.G. Cicero	129
11	Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors 2008 ·Current Clinical Pharmacology ·Giuseppe Derosa,Sibilla Salvadeo	16
12	Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin 2007 ·Internal Medicine Journal ·Giuseppe Derosa,Angela D’Angelo,P. D. Ragonesi,Leonardina Ciccarelli,Mario N. Piccinni,F. Pricolo,Sibilla Salvadeo,Lorenza Montagna,Alessia Gravina,(unknown),S. Paniga,Arrigo F.G. Cicero	37
13	Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 2007 ·Journal of Clinical Pharmacy and Therapeutics ·Giuseppe Derosa,Elena Fogari,Angela D’Angelo,Arrigo F.G. Cicero,Sibilla Salvadeo,P. D. Ragonesi,Ilaria Ferrari,Alessia Gravina,(unknown),Roberto Fogari	56
14	Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin 2007 ·Hypertension Research ·Giuseppe Derosa,Elena Fogari,Arrigo F.G. Cicero,Angela D’Angelo,Leonardina Ciccarelli,Mario N. Piccinni,F. Pricolo,Sibilla Salvadeo,Alessia Gravina,Ilaria Ferrari,Roberto Fogari	48
15	Effect of Doxazosin on C-Reactive Protein Plasma Levels and on Nitric Oxide in Patients With Hypertension 2006 ·Journal of Cardiovascular Pharmacology ·Giuseppe Derosa,Arrigo F.G. Cicero,Angela D’Angelo,Carmine Tinelli,Leonardina Ciccarelli,Mario N. Piccinni,F. Pricolo,Sibilla Salvadeo,Lorenza Montagna,Alessia Gravina,Ilaria Ferrari,Simona Galli,S. Paniga,Roberto Fogari	6
16	Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA. 2006 ·Hypertension Research ·Giuseppe Derosa,Arrigo F.G. Cicero,Angela D’Angelo,Pietro D. Ragonesi,Leonardina Ciccarelli,Mario N. Piccinni,F. Pricolo,Sibilla Salvadeo,Ilaria Ferrari,Alessia Gravina,Roberto Fogari	61
17	Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 2006 ·Journal of Clinical Pharmacy and Therapeutics ·Giuseppe Derosa,Angela D’Angelo,P. D. Ragonesi,Leonardina Ciccarelli,Mario N. Piccinni,F. Pricolo,Sibilla Salvadeo,Lorenza Montagna,Alessia Gravina,Ilaria Ferrari,S. Paniga,Arrigo F.G. Cicero	72
18	Synergistic Effect of Doxazosin and Acarbose in Improving Metabolic Control in Patients with Impaired Glucose Tolerance 2006 ·Clinical Drug Investigation ·Giuseppe Derosa,Arrigo F.G. Cicero,Angela D’Angelo,Pietro D. Ragonesi,Leonardina Ciccarelli,Elena Fogari,Sibilla Salvadeo,Ilaria Ferrari,Alessia Gravina,(unknown),Roberto Fogari	10
19	Antithrombotic Effects of Rosiglitazone‐Metformin versus Glimepiride‐Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome 2005 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Giuseppe Derosa,A. Gaddi,Mario N. Piccinni,Leonardina Ciccarelli,Sibilla Salvadeo,(unknown),(unknown),Ilaria Ferrari,Arrigo F.G. Cicero	21
20	A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 2004 ·Diabetes Research and Clinical Practice ·Giuseppe Derosa,Arrigo F.G. Cicero,A. Gaddi,Pietro D. Ragonesi,Mario N. Piccinni,Elena Fogari,Sibilla Salvadeo,Leonardina Ciccarelli,Roberto Fogari	60

About Sibilla Salvadeo

Sibilla Salvadeo is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Cancer Research, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (22 papers), Metabolism, Diabetes, and Cancer (21 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (907 citations), Cardiology and Cardiovascular Medicine (300 citations) and Pharmacology (222 citations). Sibilla Salvadeo has collaborated with scholars based in Italy and Russia. Frequent co-authors include Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo, Ilaria Ferrari, Alessia Gravina, Leonardina Ciccarelli, Mario N. Piccinni, Pamela Maffioli, Elena Fogari and Roberto Mereu. Their work appears in journals such as SHILAP Revista de lepidopterología, Metabolism and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact